Attached files
file | filename |
---|---|
10-Q - 10-Q - Bionik Laboratories Corp. | v422720_10q.htm |
EX-4.1 - EXHIBIT 4.1 - Bionik Laboratories Corp. | v422720_ex4-1.htm |
EX-31 - EXHIBIT 31 - Bionik Laboratories Corp. | v422720_ex31.htm |
EX-10.2 - EXHIBIT 10.2 - Bionik Laboratories Corp. | v422720_ex10-2.htm |
EX-10.1 - EXHIBIT 10.1 - Bionik Laboratories Corp. | v422720_ex10-1.htm |
Exhibit 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Bionik Laboratories Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Peter Bloch, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
Date: November 12, 2015 | |||
/s/ Peter Bloch | |||
Peter
Bloch Chief Executive Officer (Principal Executive Officer) |
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Bionik Laboratories Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Leslie Markow, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
Date: November 12, 2015 | |||
/s/ Leslie Markow | |||
Leslie
Markow Chief Financial Officer (Principal Financial and Accounting Officer) |